Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1798 of 6351
-
Brain zaps could reignite motivation in stroke survivors
Symptom relief CompletedThis pilot study will investigate the safety, feasibility, tolerability, and preliminary efficacy of accelerated high-dose repetitive transcranial magnetic stimulation (rTMS) targeting the medial prefrontal cortex (mPFC) to address apathy symptoms in individuals with chronic stro…
Phase 1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can cholesterol drugs or hormone therapy shield hearts in endometriosis?
Disease control By invitation onlyPurpose: To determine the effects of SERM and simvastatin interventions on endothelial dysfunction in women with endometriosis. Hypothesis: Treatment with the SERM (bazedoxifene + conjugated estrogen) or with simvastatin will decrease systemic inflammation and improve specific m…
Phase 4 • Sponsor: Penn State University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can tape or electric pulses beat exercise for neck pain?
Disease control CompletedCervical MPS is a condition of pain, weakness and loss of function caused by trigger points located in the tense bands in the muscles in the neck and upper back. Pharmacological and non-pharmacological treatments are used in the treatment of MPS. Although different treatment meth…
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Which anesthesia keeps your mind sharpest after ear surgery?
Knowledge-focused CompletedThis randomized prospective study aimed to compare desflurane, sevoflurane, and total intravenous anesthesia methods in patients undergoing elective ear surgery under controlled hypotension, with a particular focus on postoperative cognitive dysfunction. In addition to cognitive …
Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can a crocosmia bulb compound tame type 2 diabetes?
Disease control CompletedThe goal of this clinical trial is to test the investigational product, Montbretin A (MbA) in either individuals with type 2 diabetes (T2D) or healthy participants. The main questions it aims to answer are: * Safety of MbA * Whether MbA has less side effects in comparison to ot…
Phase 1 • Sponsor: Robert Petrella • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New screws could sharpen cancer imaging and treatment
Disease control Recruiting nowBackground: Spinal metastatic disease constitute a serious clinical problem in oncology. Bones are the third most common organ where metastases are located, and the spine is the place where they are most often located. Due to the complexity of the clinical problem, metastatic spi…
Sponsor: Copernicus Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Lab-Grown tumor clusters could pick best lung cancer drugs
Knowledge-focused Recruiting nowThis trial is a prospective, observational study of non-small cell lung cancer that aims to evaluate the feasibility, preliminary efficacy and safety of patient-derived tumor-like cell cluster model in guiding the precision treatment strategy.
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New study tests if ofatumumab can protect nerves in MS patients
Disease control Recruiting nowMultiple sclerosis (MS) is an immune-mediated disease characterized primarily by inflammatory demyelinating lesions in the central nervous system (CNS), with the white matter being predominantly affected. Its etiology remains unclear and may be associated with various factors suc…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Hong kong trial tests digital sleep program to stop insomnia before it starts
Prevention Recruiting nowInsomnia is one of the most common sleep disorders and affects approximately 10 - 40% of the population across different age groups in Hong Kong. Our previous study has shown that insomnia can be prevented through a brief cognitive behavioral prevention program in adolescents. Ho…
Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
CT scan could guide safer blood thinner use after TAVI
Disease control Recruiting nowThe POPular ATLANTIS trial aims to investigate CT-guided antithrombotic therapy compared to lifelong single antiplatelet therapy after a transcatheter aortic valve implantation (TAVI) procedure. Only patients without an indication for anticoagulants will be included in this trial…
Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
AI reads 2 million CT scans to spot hidden diseases
Diagnosis OngoingThis study aims to develop an AI-assisted diagnostic system for abdominal contrast-enhanced CT images using data from multiple inpatient centers. In collaboration with Alibaba DAMO Academy, the project will address key mathematical challenges limiting current automated image inte…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
One pill to tackle diabetes and cholesterol? new trial underway
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.
Phase 3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo attack on liver tumors shows promise for Tough-to-Treat cancer
Disease control CompletedLiver metastasis is the main reason that affects the survival rates of patients with colorectal cancer (CRLM), and is also the main cause of death of those patients. Especially after the failure of first-line or second-line system treatment, the prognosis of those patients is ext…
Phase 2 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a common breast cancer drug and a supplement boost sperm quality?
Disease control CompletedThis is a randomized clinical trial evaluating the efficacy of Letrozole, L-Carnitine, and their combination on sperm quality, oxidative stress, and ART outcomes in men with idiopathic oligoasthenoteratozoospermia.
Phase 2/3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can we predict who will benefit most from atrial fibrillation ablation?
Knowledge-focused CompletedAtrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions globally, with projections indicating a doubling of cases by 2050. AF is linked to heightened cardiovascular risks like stroke and increased healthcare costs. Ablation, targeting the arrhythmia substrat…
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Spinal fluid injection shows promise for tough lung cancer spread
Disease control Recruiting nowThis is a prospective, single-arm, open clinical study, which was designed to evaluate the efficacy and safety of an immune checkpoint inhibitor combined with pemetrexed intrathecal injection in the treatment of patients with NSCLC associated with leptomeningeal metastases.
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental cell therapy aims to boost immune system against Hard-to-Treat prostate cancer
Disease control CompletedThis is an open-label, phase I/IIa dose escalation and expansion study of INKmune in men with mCRPC. INKmune is administered to patients intravenously over three doses, at least one-week apart. The study will consist of two stages.
Phase 1/2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New cancer drug BNT314 enters first human safety trial
Disease control OngoingThe purpose of this first-in-human study is to find out if BNT314 is safe when it is used alone in patients with different types of cancer. This is a dose escalation study in which patients will be assigned to multiple dose levels (DLs) of BNT314 given alone. By escalating the d…
Phase 1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug MTX325 enters first human tests for Parkinson's
Disease control Recruiting nowThe goal of this trial is to learn if MTX325 can be developed as a potential disease-modifying treatment for Parkinson's Disease. Parts 1-4 complete, Part 5 (multiple doses in patients with Parkinson's Disease) in progress.
Phase 1 • Sponsor: Mission Therapeutics • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for older lymphoma patients: gentler drug combo shows promise
Disease control OngoingThis is a phase II, single-arm, open-label, multicentre study of acalabrutinib and rituximab for elderly or frail patients with previously untreated mantle cell lymphoma.
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC